Delivery Order SPE2DB24D2205-SPE2DB25FEAHE

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,443.45 firm fixed price delivery order is for the supply of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,940.48, is a delivery order for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. It is a firm fixed-price contract with a final completion date of February 4, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order valued at $3,265.08 for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The contract has a completion date of February 21, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,391.68, is a delivery order for the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of July 12, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,479.00, is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2022 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. The contract is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,627.25, is a Firm Fixed Price Delivery Order for the pharmaceutical product "MOUNJARO 5 MG/0.5 ML PEN 0.5ML". The award has an ultimate completion date of April 7, 2025 and was made on April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,679.31, is a delivery order for the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,372.02, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,088.36, is a delivery order for the pharmaceutical product "MOUNJARO 15 MG/0.5 ML PEN 0.5ML." The contract is for a firm fixed price and has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,402.01, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 18, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEAHE
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $17,437.52 and has an ultimate completion date of April 1, 2025. The contract is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The award was made on March 31, 2025 and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/30/25, 11:04 AM